Թրոմբոցիտոզ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Թրոմբոցիտոզ" in Armenian language version.

refsWebsite

Global rank Armenian rank

4^th place

3^rd place

2^nd place

4^th place

6^th place

11^th place

428^th place

719^th place

149^th place

archive.org

Kumar PJ, Clark ML (2005). «8». Clinical Medicine (Sixth ed.). Elsevier Saunders. էջեր 469. ISBN 0-7020-2763-4.
Mitchell RS, Kumar V, Abbas AK, Fausto N (2007). «Chapter 4». Robbins Basic Pathology (Eighth ed.). Philadelphia: Saunders. ISBN 978-1-4160-2973-1.

van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, Michiels JJ (September 1996). «Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation». Thrombosis and Haemostasis. 76 (3): 333–338. doi:10.1055/s-0038-1650579. PMID 8883266. S2CID 19341388.
«Management of patients with thrombophilia». Drug and Therapeutics Bulletin. 33 (1): 6–8. January 1995. doi:10.1136/dtb.1995.3316. PMID 7587981. S2CID 44647401.
Heit JA (2007). «Thrombophilia: common questions on laboratory assessment and management». Hematology. American Society of Hematology. Education Program. 2007 (1): 127–135. doi:10.1182/asheducation-2007.1.127. PMID 18024620.
Bleeker JS, Hogan WJ (2011 թ․ հունիսի 8). «Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies». Thrombosis. 2011: 536062. doi:10.1155/2011/536062. PMC 3200282. PMID 22084665.
Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, և այլք: (July 2005). «Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia». The New England Journal of Medicine. 353 (1): 33–45. doi:10.1056/NEJMoa043800. PMID 16000354.

Lu, Xiao; Chang, Richard (2023). Polycythemia Vera. Treasure Island (FL): StatPearls Publishing. PMID 32491592.
van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, Michiels JJ (September 1996). «Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation». Thrombosis and Haemostasis. 76 (3): 333–338. doi:10.1055/s-0038-1650579. PMID 8883266. S2CID 19341388.
«Management of patients with thrombophilia». Drug and Therapeutics Bulletin. 33 (1): 6–8. January 1995. doi:10.1136/dtb.1995.3316. PMID 7587981. S2CID 44647401.
Heit JA (2007). «Thrombophilia: common questions on laboratory assessment and management». Hematology. American Society of Hematology. Education Program. 2007 (1): 127–135. doi:10.1182/asheducation-2007.1.127. PMID 18024620.
Bleeker JS, Hogan WJ (2011 թ․ հունիսի 8). «Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies». Thrombosis. 2011: 536062. doi:10.1155/2011/536062. PMC 3200282. PMID 22084665.
Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, և այլք: (July 2005). «Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia». The New England Journal of Medicine. 353 (1): 33–45. doi:10.1056/NEJMoa043800. PMID 16000354.

van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, Michiels JJ (September 1996). «Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation». Thrombosis and Haemostasis. 76 (3): 333–338. doi:10.1055/s-0038-1650579. PMID 8883266. S2CID 19341388.
«Management of patients with thrombophilia». Drug and Therapeutics Bulletin. 33 (1): 6–8. January 1995. doi:10.1136/dtb.1995.3316. PMID 7587981. S2CID 44647401.